Su MBA - Star Combo CEO Director

All Insiders Australia . 
Stock . Star Combo Pharma . Stakeholders . Insider . Su MBA
S66 Stock   0.15  0.01  7.14%   

CEO

Su MBA is CEO Director of Star Combo Pharma
Address 171-177 Woodpark Road, Smithfield, NSW, Australia, 2164
Phone61 2 9756 6555
Webhttps://www.starcombo.com.au

Star Combo Management Efficiency

The company has return on total asset (ROA) of 0.0136 % which means that it generated a profit of $0.0136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0224 %, meaning that it generated $0.0224 on every $100 dollars invested by stockholders. Star Combo's management efficiency ratios could be used to measure how well Star Combo manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Star Combo's Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 1.2 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 4.3 M in 2025.
Star Combo Pharma has accumulated 4.03 M in total debt. Debt can assist Star Combo until it has trouble settling it off, either with new capital or with free cash flow. So, Star Combo's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Star Combo Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Star to invest in growth at high rates of return. When we think about Star Combo's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 12 records

CEO Age

Grant BlackleySouthern Cross Media
58
Richard BBusCharter Hall Retail
N/A
Robert CookeStar Entertainment Group
58
Mark MackayStar Entertainment Group
N/A
Daniel FinchStar Entertainment Group
N/A
Ben EllisCharter Hall Retail
N/A
Anthony BBusSuper Retail Group
51
Anthony HeraghtySuper Retail Group
50
LLB BECStar Entertainment Group
60
BEc ACASouthern Cross Media
N/A
Ciaran DavisARN Media Limited
N/A
Scott WhartonStar Entertainment Group
N/A
Star Combo Pharma (S66) is traded on Australian Securities Exchange in Australia and employs 5 people. Star Combo is listed under Personal Care Products category by Fama And French industry classification.

Management Performance

Return On Equity0.0224
Return On Asset0.0136

Star Combo Pharma Leadership Team

Elected by the shareholders, the Star Combo's board of directors comprises two types of representatives: Star Combo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Star. The board's role is to monitor Star Combo's management team and ensure that shareholders' interests are well served. Star Combo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Star Combo's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Ni, Chief Officer
He BS, Chief Officer
JinXing BS, MD Founder
FACID FAICD, Company Sec
Su MBA, CEO Director

Star Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Star Combo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0224
Return On Asset0.0136
Profit Margin0.03 %
Operating Margin0.04 %
Current Valuation16.93 M
Shares Outstanding135.08 M
Shares Owned By Insiders93.57 %
Price To Book0.61 X
Price To Sales0.78 X
Revenue26.02 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Star Stock Analysis

When running Star Combo's price analysis, check to measure Star Combo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Combo is operating at the current time. Most of Star Combo's value examination focuses on studying past and present price action to predict the probability of Star Combo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Combo's price. Additionally, you may evaluate how the addition of Star Combo to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY